Hospira quarterly earnings down on Mayne expenses
CHICAGO, Aug 8 (Reuters) - Hospira Inc. (HSP.N), a maker of hospital products and specialty pharmaceuticals, on Wednesday said its quarterly net earnings fell on costs from its acquisition of Mayne Pharma.
Second-quarter net earnings dropped to $30.7 million, or 20 cents per diluted share, from $54.2 million, or 34 cents per share, a year earlier.
Excluding special items, the Lake Forest, Illinois-based company said it had earned 49 cents per share.
Wall Street analysts on average had forecast profit of 48 cents a share excluding one-time items, according to Reuters Estimates.
Quarterly sales jumped nearly 30 percent to $869.4 million, fueled by Mayne results. Excluding Mayne, sales grew just 2.8 percent. (Reporting by Debra Sherman)
© Thomson Reuters 2009 All rights reserved
Citadel enters the fray
Kenneth Griffin's powerful hedge fund has waded into the case of Goldman Sachs' purloined computer code, suing three of its former employees for setting up Teza Technologies. Full Article | Full Coverage
